Joseph D. Buxbaum, PhD, Elected to the National Academy of Medicine
Thursday, October 29, 2015
Posted by: Andrew Law
We are pleased to announce that Joseph D. Buxbaum, PhD, has been elected to the prestigious National Academy of Medicine (NAM), formerly known as the Institute of Medicine. Dr. Buxbaum is Professor and Vice Chair for Research in the Department of Psychiatry, and Director of the Seaver Autism Center for Research and Treatment at the Icahn School of Medicine at Mount Sinai.
New members to the NAM are elected by current active members through a selective process that recognizes people who have made major contributions to the advancement of the medical sciences, health care, and public health. Dr. Buxbaum’s election is recognition of his important contributions to uncovering the genetic and molecular basis of autism spectrum disorder.
A world-renowned molecular geneticist and neurobiologist, Dr. Buxbaum’s research focuses on using techniques of molecular genetics and neuroscience to identify and characterize genes that contribute to autism susceptibility. His laboratory has identified common and rare genetic variants that underlie autism and has developed model systems in which novel therapeutics can be tested. His work has led to clinical trials in rare genetic disorders associated with autism.
Dr. Buxbaum joined Mount Sinai in 1997 as the Director of Molecular Genetics in the Seaver Autism Center, of which he became Director in 2008. Under his leadership, the Seaver Autism Center has grown significantly and expanded the impact of its translational research in the field of autism.
Dr. Buxbaum earned his PhD from the Weizmann Institute of Science in Rehovot, Israel, and completed a post-doctoral fellowship in the Laboratory of Molecular and Cellular Neuroscience at Rockefeller University in New York City. He is the author of more than 200 publications, and is co-editor in chief of the journal Molecular Autism.
Please join us in congratulating Dr. Buxbaum on this impressive honor.